Liqomics

Name	:	Liqomics
Website	:	Visit Website
Blog	:	Visit Blog
Social Links	:

About Liqomics

LIQOMICS pioneers in circulating tumor DNA (ctDNA) detection through non-invasive liquid biopsy methods. Our state-of-the-art technology identifies genetic alterations in the bloodstream, providing real-time insights into tumor dynamics. This enables clinicians to make informed decisions and tailor treatments effectively. Choose LIQOMICS for cutting-edge ctDNA analysis in cancer diagnostics.

Experience Non-Invasive Cancer Diagnostics with LIQOMICS' Blood-Based Tests

Liqomics02 Nov, 2025Health

Curious about detecting relapses earlier? LIQOMICS’ blood-based tests offer precise insights for lymphoma and other cancers with its liquid biopsy technology, helping monitor treatment and detect relapses early—simplifying care without traditional biopsies.

Trust LIQOMICS For Accurate And Timely Cancer Diagnostics

Liqomics27 Oct, 2025Health

Trust LIQOMICS for accurate and timely cancer diagnostics. Our advanced liquid biopsy enables precise minimal residual disease testing, helping detect relapse early, monitor treatment, and guide personalized care—all through a simple, non-invasive blood test.

Non-Invasive ctDNA Testing by LIQOMICS – Track Cancer with Ease

Liqomics15 Oct, 2025Health

Looking for an easy way to track cancer? LIQOMICS provides non-invasive ctDNA testing for precise, reliable results. Our circulating tumor DNA test ensures advanced, stress-free cancer monitoring with trusted genomic insights and ongoing patient support.